124 related articles for article (PubMed ID: 2548110)
1. The noncompetitive N-methyl-D-aspartate receptor antagonist, MK-801 profoundly reduces volatile anesthetic requirements in rabbits.
Scheller MS; Zornow MH; Fleischer JE; Shearman GT; Greber TF
Neuropharmacology; 1989 Jul; 28(7):677-81. PubMed ID: 2548110
[TBL] [Abstract][Full Text] [Related]
2. Effects of the NMDA receptor antagonist MK-801 against amygdaloid-kindled seizures in the rat.
Young NA; Lewis SJ; Vajda FJ; Beart PM
Exp Neurol; 1989 Feb; 103(2):199-202. PubMed ID: 2536332
[TBL] [Abstract][Full Text] [Related]
3. The topography of MK-801-induced locomotor patterns in rats.
Ford LM; Norman AB; Sanberg PR
Physiol Behav; 1989 Oct; 46(4):755-8. PubMed ID: 2557649
[TBL] [Abstract][Full Text] [Related]
4. Structure and activity of hydrogenated derivatives of (+)-5-methyl-10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5,10-imine (MK-801).
Lyle TA; Magill CA; Britcher SF; Denny GH; Thompson WJ; Murphy JS; Knight AR; Kemp JA; Marshall GR; Middlemiss DN
J Med Chem; 1990 Mar; 33(3):1047-52. PubMed ID: 2155319
[TBL] [Abstract][Full Text] [Related]
5. Kinetics of MK-801 and its effect on quinolinic acid-induced seizures and neurotoxicity in rats.
Vezzani A; Serafini R; Stasi MA; Caccia S; Conti I; Tridico RV; Samanin R
J Pharmacol Exp Ther; 1989 Apr; 249(1):278-83. PubMed ID: 2540317
[TBL] [Abstract][Full Text] [Related]
6. Effect of a noncompetitive antagonist (MK-801) of NMDA receptors on convulsions and brain amino acid level in E1 mice.
Sato K; Morimoto K; Hiramatsu M; Mori A; Otsuki S
Neurochem Res; 1989 Aug; 14(8):741-4. PubMed ID: 2554174
[TBL] [Abstract][Full Text] [Related]
7. Anticonvulsant action of a non-competitive antagonist of NMDA receptors (MK-801) in the kindling model of epilepsy.
Sato K; Morimoto K; Okamoto M
Brain Res; 1988 Oct; 463(1):12-20. PubMed ID: 2848606
[TBL] [Abstract][Full Text] [Related]
8. Interaction between GABAergic anticonvulsants and the NMDA receptor antagonist MK 801 against MES- and picrotoxin-induced convulsions in rats.
Kulkarni SK; Ticku MK
Life Sci; 1989; 44(18):1317-23. PubMed ID: 2541293
[TBL] [Abstract][Full Text] [Related]
9. Anticonvulsant and antiepileptogenic actions of MK-801 in the kindling and electroshock models.
McNamara JO; Russell RD; Rigsbee L; Bonhaus DW
Neuropharmacology; 1988 Jun; 27(6):563-8. PubMed ID: 2843782
[TBL] [Abstract][Full Text] [Related]
10. The noncompetitive N-methyl-D-aspartate antagonists, MK-801, phencyclidine and ketamine, increase the potency of general anesthetics.
Daniell LC
Pharmacol Biochem Behav; 1990 May; 36(1):111-5. PubMed ID: 2190239
[TBL] [Abstract][Full Text] [Related]
11. Maturation of the hypothalamic control of pulsatile gonadotropin-releasing hormone secretion at onset of puberty. I. Increased activation of N-methyl-D-aspartate receptors.
Bourguignon JP; Gerard A; Mathieu J; Mathieu A; Franchimont P
Endocrinology; 1990 Aug; 127(2):873-81. PubMed ID: 2164923
[TBL] [Abstract][Full Text] [Related]
12. In vivo labelling of the NMDA receptor channel complex by [3H]MK-801.
Price GW; Ahier RG; Middlemiss DN; Singh L; Tricklebank MD; Wong EH
Eur J Pharmacol; 1988 Dec; 158(3):279-82. PubMed ID: 2472964
[TBL] [Abstract][Full Text] [Related]
13. [3H]MK-801 binding in Alzheimer's disease.
Mouradian MM; Contreras PC; Monahan JB; Chase TN
Neurosci Lett; 1988 Nov; 93(2-3):225-30. PubMed ID: 2853845
[TBL] [Abstract][Full Text] [Related]
14. Systematic studies on the effects of the NMDA receptor antagonist MK-801 on cerebral blood flow and responsivity, EEG, and blood-brain barrier following complete reversible cerebral ischemia.
Stevens MK; Yaksh TL
J Cereb Blood Flow Metab; 1990 Jan; 10(1):77-88. PubMed ID: 2153692
[TBL] [Abstract][Full Text] [Related]
15. Cardiovascular effects of the N-methyl-D-aspartate receptor antagonist MK-801 in conscious rats.
Lewis SJ; Barres C; Jacob HJ; Ohta H; Brody MJ
Hypertension; 1989 Jun; 13(6 Pt 2):759-65. PubMed ID: 2544522
[TBL] [Abstract][Full Text] [Related]
16. The NMDA-receptor antagonist, MK-801, suppresses limbic kindling and kindled seizures.
Gilbert ME
Brain Res; 1988 Oct; 463(1):90-9. PubMed ID: 2848609
[TBL] [Abstract][Full Text] [Related]
17. The effect of NMDA antagonists in the radial arm maze task with an interposed delay.
Butelman ER
Pharmacol Biochem Behav; 1990 Mar; 35(3):533-6. PubMed ID: 2160086
[TBL] [Abstract][Full Text] [Related]
18. Anticataleptic effects of the N-methyl-D-aspartate antagonist MK-801 in rats.
Schmidt WJ; Bubser M
Pharmacol Biochem Behav; 1989 Mar; 32(3):621-3. PubMed ID: 2544900
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms of phencyclidine (PCP)-n-methyl-d-aspartate (NMDA) receptor interaction: implications for drug abuse research.
Zukin SR; Javitt DC
NIDA Res Monogr; 1989; 95():247-54. PubMed ID: 2561829
[No Abstract] [Full Text] [Related]
20. Comparison of the behavioral and biochemical effects of the NMDA receptor antagonists, MK-801 and phencyclidine.
Hiramatsu M; Cho AK; Nabeshima T
Eur J Pharmacol; 1989 Aug; 166(3):359-66. PubMed ID: 2553433
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
